lung cancer | |||||
新闻 | |||||
Domvanalimab Combination Shows Clinically Meaningful Progression-Free Survival in Lung Cancer ... trial shows that a combination of Fc-silent anti-TIGIT and anti-PD-1 molecules are effective for objective response rates in certain lung cancers.
| |||||
| |||||
Existing drug could reduce side effects of popular cancer treatment - ScienceDaily Currently, cisplatin is used to treat testicular, ovarian, bladder, lung, stomach and head and neck cancers. While cisplatin has proven to be an ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment